Afghanistan’s pharmaceutical sector presents one of the most compelling opportunities
for domestic manufacturing in the region.
With 90% of medicines imported and uncertain borders, local production is a strategic necessity for Afghanistan.
Strong Afghan government backing including tariff exemptions and restrictions on competing imports.
Domestic manufacturing eliminates supply chain vulnerabilities from cross-border trade conditions.
Targeting 5–10% domestic market share — representing USD 42–85M at current market size.
Kandahar's strategic location enables access to regional markets beyond Afghanistan's borders.
A growing population of ~45 million ensures expanding long-term pharmaceutical demand across all segments.